CORC

浏览/检索结果: 共69条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui
收藏  |  浏览/下载:25/0  |  提交时间:2022/12/23
Safety issues and mechanisms of lithium-ion battery cell upon mechanical abusive loading: A review 期刊论文
Energy Storage Materials, 2020, 卷号: 24, 页码: 85-112
作者:  Liu, Binghe;  Jia, Yikai;  Yuan, Chunhao;  Wang, Lubing;  Gao, Xiang
收藏  |  浏览/下载:52/0  |  提交时间:2019/12/30
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology 期刊论文
CANCER BIOLOGY & MEDICINE, 2019, 卷号: 16, 期号: 1
作者:  Wu, Chunyan;  Shao, Zhimin;  Xu, Binghe;  Zhang, Qingyuan;  Xu, Ruihua
收藏  |  浏览/下载:121/0  |  提交时间:2019/12/05
A Simultaneous Multiscale and Multiphysics Model and Numerical Implementation of a Core-Shell Model for Lithium-Ion Full-Cell Batteries 期刊论文
Journal of Applied Mechanics, 2019, 卷号: Vol.86 No.4, 页码: 041005
作者:  Binghe Liu;  Xu Wang;  Hao-Sen Chen;  Sen Chen;  Hongxin Yang
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/17
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载:32/0  |  提交时间:2020/01/03
Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis 期刊论文
2019, 卷号: 11, 页码: 4699-4706
作者:  Han, Yiqun;  Wang, Jiayu;  Liu, Weiming;  Yuan, Peng;  Li, Qing
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study 期刊论文
2019, 卷号: 19, 期号: 1, 页码: 442
作者:  Yi, Zongbi;  Ma, Fei;  Liu, Binliang;  Guan, Xiuwen;  Li, Lixi
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers 期刊论文
2019, 卷号: 19, 期号: 1, 页码: 279
作者:  Fan, Ying;  Li, Shu;  Ding, Xiaoyan;  Yue, Jian;  Jiang, Jun
收藏  |  浏览/下载:15/0  |  提交时间:2020/01/03
Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 16
作者:  Huang, Jing;  Xu, Binghe;  Liu, Ying;  Huang, Junxing;  Lu, Ping
收藏  |  浏览/下载:31/0  |  提交时间:2020/01/03
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology 期刊论文
2019, 卷号: 16, 期号: 1, 页码: 189-204
作者:  Zhang Xuchao;  Liang Zhiyong;  Wang Shengyue;  Lu Shun;  Song Yong
收藏  |  浏览/下载:25/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace